000 01317 a2200361 4500
005 20250513124044.0
264 0 _c19970919
008 199709s 0 0 eng d
022 _a0014-4886
024 7 _a10.1006/exnr.1997.6562
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aJanson, A M
245 0 0 _aChronic nicotine treatment differentially regulates substance P and tyrosine hydroxylase immunoreactivity in substantia nigra ipsilateral to a unilateral lesion.
_h[electronic resource]
260 _bExperimental neurology
_cAug 1997
300 _a575-86 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAnimals
650 0 4 _aCorpus Striatum
_xmetabolism
650 0 4 _aDenervation
650 0 4 _aMale
650 0 4 _aNeuroprotective Agents
_xpharmacology
650 0 4 _aNicotine
_xpharmacology
650 0 4 _aRats
650 0 4 _aRats, Sprague-Dawley
650 0 4 _aSubstance P
_xmetabolism
650 0 4 _aSubstantia Nigra
_xmetabolism
650 0 4 _aSynaptic Transmission
650 0 4 _aTime Factors
650 0 4 _aTyrosine 3-Monooxygenase
_xmetabolism
700 1 _aFuxe, K
773 0 _tExperimental neurology
_gvol. 146
_gno. 2
_gp. 575-86
856 4 0 _uhttps://doi.org/10.1006/exnr.1997.6562
_zAvailable from publisher's website
999 _c9249570
_d9249570